Biopharma Business

Toxicology

Strategic alliance formed between Sygnature and ApconiX

    Strategic alliance formed between Sygnature and ApconiX

A strategic alliance between Sygnature Discovery, provider of integrated drug discovery resource and expertise, and ApconiX, non-clinical safety strategies and ion channel screening experts, has been announced. The partnership will

Read Full Article

HIV market to grow to $22.5bn by 2025

This growth is across the nine major countries of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil and China The human immunodeficiency virus (HIV) market is set to

Read Full Article

Impax Launches Generic Version of Vytorin

Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. Food and Drug Administration (FDA) approval for a generic version of Vytorin (ezetimibe/simvastatin tablets), 10/10, 10/20, 10/40 and 10/80

Read Full Article

Phase 3 readout keeps Amgen in pole position for CGRP migraine drug

Amgen has firmed up its lead in the race to bring the first CGRP inhibitor to market for migraine after presenting positive results from its two phase 3 trials. The

Read Full Article

NHS Wales to use information management for paediatric diabetes

A new project in Wales will enable all NHS Wales Paediatric Diabetes Units to collect patient information in a consistent manner. The national project, funded by the Welsh government, involves

Read Full Article

LSTM reports on a new way of screening potential treatments for TB

Scientists from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB)

Read Full Article

Researchers Crack Structure of Key Protein in Zika Virus

Zika virus (ZIKV), which causes Zika virus disease, is spread to people primarily through the bite of an infected Aedes aegypti or Aedes albopictus mosquito. An infected pregnant woman can pass ZIKV to her

Read Full Article

Sanofi and Voluntis announce digital insulin agreement

Global healthcare company Sanofi and therapeutic companion software company Voluntis have agreed to a collaboration to help improve decision-making and self-management for type 2 diabetics treated with basal insulin. The

Read Full Article

Mylan recalls 80,000 EpiPens

Drugmaker Mylan has recalled over 80,000 EpiPens across the world due to reports of the device failing to activate. The recall comes after two instances of the device not working

Read Full Article

Debiopharm’s triptorelin 6-month formulation receives EU approval

Debiopharm International, a Swiss-based company, part of Debiopharm Group, announced that triptorelin 6-month formulation (Decapeptyl and Pamorelin 22.5 mg) received approval for the treatment of central precocious puberty (CPP) in

Read Full Article

Antioxidants and lung cancer risk

An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer. The study authors found that vitamin C

Read Full Article

EU Grants Orphan Drug Designation for Epidermolysis Bullosa Treatment

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has

Read Full Article

Merck and Pfizer’s diabetes therapy under US, EU review

Regulators on both sides of the Atlantic are reviewing three new submissions for medicines containing ertugliflozin, an investigational SGLT2 inhibitor being developed by Merck and Pfizer to help improve glycaemic

Read Full Article

Sanofi and AstraZeneca to Collaborate on Antibody for Prevention of Respiratory Illnesses

Sanofi and its vaccines global business unit Sanofi Pasteur announced today an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to develop and commercialize a monoclonal antibody–called MEDI8897–for the

Read Full Article

Volkswagen’s excess emissions will lead to 1,200 premature deaths in Europe

In September 2015, the German Volkswagen Group, the world’s largest car producer, admitted to having installed “defeat devices” in 11 million diesel cars sold worldwide between 2008 and 2015. The

Read Full Article

Gene Therapy Lets a French Teen Dodge Sickle Cell Disease

A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of

Read Full Article

The Dirty Dozen: UN Issues List of 12 Most Worrying Bacteria

The World Health Organization has issued a list of the top dozen bacteria most dangerous to humans, warning that doctors are fast running out of treatment options. In a press

Read Full Article

EMA Recommends Six Medicines for Market Approval

On Feb. 24, 2017, the European Medicines Agency (EMA) announced that its Committee for Medicinal Products for Human Use (CHMP) recommended six medicines for market authorization in the European Union, including an

Read Full Article

Orphan Drug Natpar Receives EMA Recommendation

The European Medicines Agency (EMA) announced on Feb. 24, 2017 that its Committee for Medicinal Products for Human Use (CHMP) has granted conditional marketing authorization in the European Union to Natpar

Read Full Article

EU Approves New Single-Dose Delivery Option for Repatha

Amgen announced that the European Commission (EC) has adopted a decision to change the Repatha (evolocumab) marketing authorization, approving a new single-dose delivery option. The new automated mini-doser (AMD) with a

Read Full Article

GSK Reports Positive Results for Once-Daily Inhaled Corticosteroid

GlaxoSmithKline plc and Innoviva, Inc. announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were able to switch to the once-daily Relvar Ellipta (fluticasone furoate/vilanterol,

Read Full Article

Cambridge Research Biochemicals announces new antibodies catalogue

Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new Discovery Antibodies catalogue. The company’s new product range will offer the

Read Full Article

Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market

Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition

Read Full Article

Biogen to remain leader in neurodegenerative drugs

Roche’a anticipated approval of ocrelizumab will drive the company’s share of the market from <1% in 2016 to 15% by

Read Full Article

EMA examines key Actelion med Uptravi following 5 patient deaths in France

Johnson & Johnson is counting on new buy Actelion’s pulmonary arterial hypertension (PAH) meds to provide a top-line boost once

Read Full Article

EU approval for Sanofi’s type 2 diabetes treatment

The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin

Read Full Article

New drug for treatment of aggressive breast cancer found by Irish researchers

As recently published in the International Journal of Cancer, researchers from Breast-Predict, may have found a new drug for the

Read Full Article

Upcoming Events

  • November 12, 2018Compamed
  • November 13, 2018Foodpharmatech
  • April 21, 2019Labvolution
AEC v1.0.4

The Magazine

New Subscriber





Subscribe Here



Advertisements